You will not be allowed to compare more than 4 products at a time
View compareDescription
Sobrefluid children 100 mg suppositories
sobrerol
What it is and what it is used for
The active ingredient in Sobrefluid is sobrerol, a mucolytic.
This medicine is indicated to facilitate the removal of excess mucus in acute and chronic respiratory tract conditions.
The duration of treatment should not exceed 3 days.
What you need to know before taking the medicine
Do not use Sobrefluid
- if you are allergic to sobrerol or any of the other ingredients of this medicine (listed in section 6);
- if you are pregnant or breastfeeding. (see “Pregnancy and breastfeeding”);
- in children under 30 months of age;
- in children with a history of epilepsy or febrile seizures;
- in children with a recent history of anorectal injury.
Warnings and precautions
Consult your doctor or pharmacist before using Sobrefluid.
Pay particular attention:
This medicine contains sobrerol which, in excessive doses, can induce neurological disorders such as convulsions in infants and children.
Do not prolong treatment for more than 3 days due to the risks associated with the accumulation of terpene derivatives in the body, including the brain, and in particular due to the risks of neuropsychological disorders.
Do not administer doses higher than those recommended to avoid a greater risk of adverse drug reactions and disorders associated with overdose.
The product is flammable, do not approach flames.
Children
The product should not be used in children under 30 months of age, as mucolytics can induce bronchial occlusion (the ability to eliminate bronchial mucus in children under 30 months is limited due to the characteristics of their respiratory tracts).
Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Side effects with unknown frequency (frequency cannot be estimated from the available data):
- allergic (hypersensitivity) reactions manifesting as itching, rash, hives, edema and dyspnea; bronchial obstruction (temporary narrowing of the upper respiratory tract);
- gastric (stomach) disorders;
- nausea.
Reporting of side effects
If you get any side effects, including any not listed in this leaflet, talk to your doctor or pharmacist. You can also report side effects directly via the national reporting system at: https://www.aifa.gov.it/content/segnalazionireazioni-avverse.
By reporting side effects you can help provide more information on the safety of this medicine.




